GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Gross Margin %

Mankind Pharma (BOM:543904) Gross Margin % : 68.25% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Mankind Pharma's Gross Profit for the three months ended in Dec. 2023 was ₹17,794 Mil. Mankind Pharma's Revenue for the three months ended in Dec. 2023 was ₹26,070 Mil. Therefore, Mankind Pharma's Gross Margin % for the quarter that ended in Dec. 2023 was 68.25%.


The historical rank and industry rank for Mankind Pharma's Gross Margin % or its related term are showing as below:

BOM:543904' s Gross Margin % Range Over the Past 10 Years
Min: 67.21   Med: 68.26   Max: 70.63
Current: 68.68


During the past 3 years, the highest Gross Margin % of Mankind Pharma was 70.63%. The lowest was 67.21%. And the median was 68.26%.

BOM:543904's Gross Margin % is ranked better than
83.2% of 988 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs BOM:543904: 68.68

Mankind Pharma had a gross margin of 68.25% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mankind Pharma was 0.00% per year.


Mankind Pharma Gross Margin % Historical Data

The historical data trend for Mankind Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Gross Margin % Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22
Gross Margin %
67.21 70.63 68.26

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.76 67.55 68.20 69.54 68.25

Competitive Comparison of Mankind Pharma's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Gross Margin % falls into.



Mankind Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Mankind Pharma's Gross Margin for the fiscal year that ended in Mar. 2022 is calculated as

Gross Margin % (A: Mar. 2022 )=Gross Profit (A: Mar. 2022 ) / Revenue (A: Mar. 2022 )
=53115.5 / 77815.55
=(Revenue - Cost of Goods Sold) / Revenue
=(77815.55 - 24700.08) / 77815.55
=68.26 %

Mankind Pharma's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=17793.7 / 26069.589
=(Revenue - Cost of Goods Sold) / Revenue
=(26069.589 - 8275.893) / 26069.589
=68.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Mankind Pharma  (BOM:543904) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mankind Pharma had a gross margin of 68.25% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mankind Pharma Gross Margin % Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines